With the deal, Austin, Texas-based Function adds to its clinical lab offerings, allowing its members to schedule at-home or in-office blood draws.

The company said its BD Onclarity HPV Self-Collection Kit will improve access to testing for human papillomavirus, which is the main cause of cervical cancer.

MedStar Health will deploy PathAI's AISight for the more than 40 pathologists at its multi-site health system serving the Washington, D.C. area.

Last week, readers were most interested in a story about Baebies' multifunctional POC system that offers molecular testing alongside another test modality.

The platform enables collection of breath samples from the deep lung while eliminating contamination from the mouth, upper airways, and environment.

The oversubscribed round will support final assay development and manufacturing readiness for an early access program launch.

The study included 3,014 patients evaluated based on high-risk screening, symptomatic presentation, or identification of a mass on imaging.

The researchers measured ctDNA in women with breast cancer over 70 years of age before beginning endocrine therapy and ...

While the effort could bring new requirements to the reimbursement process, it could also make payments more standardized and ...

The clinical trial is designed to catch cancer at its earliest molecular signal and intervene before it becomes metastatic.

The FDA clearances address laboratory challenges including staff shortages, limited space, and rising test volumes, the firm said.

Last week, readers were most interested in a story about Roche's molecular respiratory panel receiving CE marking.